Diego A. Díaz García, Medical Oncologist / CEO / Founder at CánCare – Advanced Specialty in Oncology, shared a post on X:
“Metabolism meets immunotherapy.
Targeting metabolic pathways like adenosine and tryptophan is emerging as a strategy to boost antitumor immunity and overcome resistance to ICIs or CAR-T.”
Title: Metabolites as agents and targets for cancer immunotherapy
Authors: Marcel P. Trefny, Guido Kroemer, Laurence Zitvogel, Sebastian Kobold
Read the Full Article.
More posts featuring Diego Díaz García.
